Asher Chanan‐Khan

Also affiliated with Mayo Clinic in Florida

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Long-term outcomes for newly-diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre phase II study”.

Long-term outcomes for newly-diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre phase II study

UNC Libraries(2020)10.17615/q2fj-2t55

N/A

0DataRank · unranked

0 citations

Flora Mulkey, Robert Z. Orlowski, Ben L. Sanford, Richard A. Larson, Susan M. Geyer +5 more

CD38 as a multifaceted immunotherapeutic target in CLL

Leukemia & lymphoma/Leukemia and lymphoma(2022)10.1080/10428194.2022.2090551

N/A

0DataRank · unranked

12 citations

Fabio Malavasi, Asher Chanan‐Khan, Aneel Paulus